PhD Recruitment Process2020-10-04T21:39:29+00:00

Applications – CoL Centre and RadNet PhD studentships

Applications must be submitted through the Crick’s online academic recruitment system.
Before beginning an application, you should read the information on this page and the “completing the application form” page. You should also find out about the projects being offered to start in September 2021 and their supervisors via the specific Project Pages (see below).
You must complete all required sections of the application form in full.

Key dates

Your application must be submitted by the deadline: 12 noon, 16 November 2020
We will not accept late applications.
We should receive your references by 23 November 2020. Your application may still be considered if references are not received by this deadline. However, no applicant will be invited to interview unless references have been received.
You will find out if you have been invited to interview for the programme by:  5 January  2021.
Interviews will take place: Week commencing 1 February 2021
Programme start date:  September 2021

Interviews

Interviews will take place the week commencing 1 February 2021. During the interview, candidates will be interviewed by a panel of CRUK CoL faculty. Please note that not all projects will be funded and studentships will be awarded to the best applicants based on information submitted on the application form, references and performance during the interview.

 

PhD Projects available

Project 1. Investigation of the molecular mechanisms and microenvironmental cues driving adaptive resistance to FLT3 targeted therapy in acute myeloid leukaemia. Primary Supervisor: Dr Paolo Gallipoli, Barts Cancer Institute, Queen Mary University of London. Secondary Supervisor: Prof Cristina Lo Celso The Francis Crick Institute and Imperial College London.

Project 2. Prognostic value and functional role of germinal centers in lymph nodes of immunotherapy treated breast cancers. Primary Supervisor: Dr Anita Grigoriadis, Cancer and Pharmaceutical Sciences, King’s College London. Secondary Supervisor: Dr Dinis Calado Immunity and Cancer Laboratory, The Francis Crick Institute

Project 3. A novel strategy to eliminate solid cancers by combining oncolytic adenoviruses and epigenetic drugs to activate the host anti-tumour immune-responses. Primary Supervisor: Dr Gunnel Halldén, Centre for Biotherapeutics and Biomarkers, Barts Cancer Institute, QMUL. Secondary Supervisor: Dr Michelle Holland Department of Medical and Molecular Genetics, King’s College London

Project 4. Forecasting immune selection and evasion in mismatch repair deficient cancer through evolutionary modelling. Primary Supervisor: Dr Marnix Jansen, UCL Cancer Institute, University College London. Secondary Supervisor: Dr Ben Werner, Barts Cancer Institute, Queen Mary University of London. Tertiary Supervisor: Dr Nischalan Pillay, UCL Cancer Institute, University College London

Project 5. Understanding myeloid heterogeneity in premetastatic niches following cytotoxic therapy. Primary Supervisor: Dr Ioanna Keklikoglou, Barts Cancer Institute, Queen Mary University of London. Secondary Supervisor: Dr Chris Tape, UCL Cancer Institute, University College London. Tertiary Supervisor: Prof Frances Balkwill, Barts Cancer Institute, Queen Mary University of London

Project 6. Understanding the origin and the function of metabolic reprogramming in cancer associated neutrophils within the metastatic niche. Primary Supervisor: Dr Luigi Ombrato, Barts Cancer Institute, QMUL. Secondary Supervisor: Dr Mariia Yuneva, The Francis Crick Institute. Tertiary Supervisor: Prof Kairbaan Hodivala-Dilke, Barts Cancer Institute, QMUL

Project 7. Modelling and functional characterisation of tumour heterogeneity in human AML arisen from different cells-of-origin with single cell multi-omics approaches. Primary Supervisor: Prof Eric So, School of Cancer and Pharmaceutical Sciences, King’s College London. Secondary Supervisor: Prof Adrian Thrasher, Infection, Immunity, Inflammation Programme, University College London

Project 8. Development of PET/PDT theranostics for Leukaemia/Lymphoma. Primary Supervisor: Dr Graeme Stasiuk, School of Biomedical Engineering and Imaging Science, King’s College London. Secondary Supervisor: Dr Kerstin Sander, Centre for Radiopharmaceutical Chemistry, University College London

 

RadNet PhD Projects available

Project 1. The role of T cell immunity in responses to radiotherapy in rectal cancer. Primary Supervisor: Prof Benny Chain, Infection and Immunity, University College London. Secondary Supervisor: Prof Trevor Graham, Barts Cancer Institute, Queen Mary University of London. Tertiary Supervisors: Dr Jamie Murphy, Division of Surgery and Cancer, Imperial College London and Dr Dorothy Gurjal ,Imperial College Healthcare NHS Trust.

Project 2. Understanding the links between radio-resistance, tumour invasiveness and immunosuppression. Primary Supervisor: Dr Gilbert Fruhwirth, Biomedical Engineering and Imaging Sciences, King’s College London. Secondary Supervisor: Prof Vicky Sanz-Moreno, Barts Cancer Institute, Queen Mary University of London

Project 3. Exploiting radiation to improve the outcome of centrosome-based therapies. Primary Supervisor: Dr Susana Godinho, Barts Cancer Institute, Queen Mary University of London. Secondary Supervisor: Prof Gary Royle, Department of Medical Physics and Biomedical Engineering, University College London

Project 4. The role of microtubule-associated proteins in cellular response to gamma irradiation. Primary Supervisor: Dr Zuzana Horejsi, Barts Cancer Institute, Queen Mary University of London. Secondary Supervisor: Prof Maddy Parsons, Randall Centre for Cell and Molecular Biophysics, King’s College London

Project 5. Targeting hypoxia tolerance mechanisms in head and neck cancer. Primary Supervisor: Prof Mahvash Tavassoli, Centre for Host Microbiome Interactions, King’s College London. Secondary Supervisor: Dr Adrian Biddle, Blizard Institute, Queen Mary University of London

 

 

How to apply